505 related articles for article (PubMed ID: 19398068)
1. Current status of Kampo (Japanese herbal) medicines in Japanese clinical practice guidelines.
Motoo Y; Arai I; Hyodo I; Tsutani K
Complement Ther Med; 2009 Jun; 17(3):147-54. PubMed ID: 19398068
[TBL] [Abstract][Full Text] [Related]
2. Toxicological considerations of Kampo medicines in clinical use.
Ikegami F; Fujii Y; Satoh T
Toxicology; 2004 May; 198(1-3):221-8. PubMed ID: 15138045
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study on the original plant differences of Chinese traditional medicines and Japanese Kampo medicines].
Chen HB; Cai SQ; Mikage M; Naoko K
Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):715-8, 822. PubMed ID: 15506274
[TBL] [Abstract][Full Text] [Related]
4. Incidence and clinical features of liver injury related to Kampo (Japanese herbal) medicine in 2,496 cases between 1979 and 1999: problems of the lymphocyte transformation test as a diagnostic method.
Mantani N; Kogure T; Sakai S; Goto H; Shibahara N; Kita T; Shimada Y; Terasawa K
Phytomedicine; 2002 May; 9(4):280-7. PubMed ID: 12120808
[TBL] [Abstract][Full Text] [Related]
5. Identification of a predictive biomarker for the beneficial effect of a Kampo (Japanese traditional) medicine keishibukuryogan in rheumatoid arthritis patients.
Ogawa K; Kojima T; Matsumoto C; Kamegai S; Oyama T; Shibagaki Y; Muramoto H; Kawasaki T; Fujinaga H; Takahashi K; Hikiami H; Goto H; Kiga C; Koizumi K; Sakurai H; Shimada Y; Yamamoto M; Terasawa K; Takeda S; Saiki I
Clin Biochem; 2007 Oct; 40(15):1113-21. PubMed ID: 17673196
[TBL] [Abstract][Full Text] [Related]
6. Regulation of traditional herbal medicinal products in Japan.
Maegawa H; Nakamura T; Saito K
J Ethnopharmacol; 2014 Dec; 158 Pt B():511-5. PubMed ID: 25043783
[TBL] [Abstract][Full Text] [Related]
7. Kampo medicines as alternatives for treatment of migraine: six case studies.
Ishida K; Sato H
Complement Ther Clin Pract; 2006 Nov; 12(4):276-80. PubMed ID: 17030300
[TBL] [Abstract][Full Text] [Related]
8. Regulation of herbal medicines in Japan.
Saito H
Pharmacol Res; 2000 May; 41(5):515-9. PubMed ID: 10753549
[TBL] [Abstract][Full Text] [Related]
9. [The utilization and safety of medicinal plants and crude drugs].
Satake M
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):13-29. PubMed ID: 10097510
[TBL] [Abstract][Full Text] [Related]
10. Levels of evidence in cardiovascular clinical practice guidelines.
Ackman ML; Druteika D; Tsuyuki RT
Can J Cardiol; 2000 Oct; 16(10):1249-54. PubMed ID: 11064299
[TBL] [Abstract][Full Text] [Related]
11. Developing search strategies for clinical practice guidelines in SUMSearch and Google Scholar and assessing their retrieval performance.
Haase A; Follmann M; Skipka G; Kirchner H
BMC Med Res Methodol; 2007 Jun; 7():28. PubMed ID: 17603909
[TBL] [Abstract][Full Text] [Related]
12. Four cases of panic disorder successfully treated with Kampo (Japanese herbal) medicines: Kami-shoyo-san and Hange-koboku-to.
Mantani N; Hisanaga A; Kogure T; Kita T; Shimada Y; Terasawa K
Psychiatry Clin Neurosci; 2002 Dec; 56(6):617-20. PubMed ID: 12485303
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use.
Ikegami F; Sumino M; Fujii Y; Akiba T; Satoh T
Hum Exp Toxicol; 2006 Aug; 25(8):481-94. PubMed ID: 16937920
[TBL] [Abstract][Full Text] [Related]
14. Status of urological Kampo medicine: a narrative review and future vision.
Minagawa T; Ishizuka O
Int J Urol; 2015 Mar; 22(3):254-63. PubMed ID: 25597936
[TBL] [Abstract][Full Text] [Related]
15. Diet and Japanese herbal medicine for recalcitrant atopic dermatitis: efficacy and safety.
Kobayashi H; Mizuno N; Teramae H; Kutsuna H; Ueoku S; Onoyama J; Yamanaka K; Fujita N; Ishii M
Drugs Exp Clin Res; 2004; 30(5-6):197-202. PubMed ID: 15700746
[TBL] [Abstract][Full Text] [Related]
16. Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances.
Terauchi M; Hiramitsu S; Akiyoshi M; Owa Y; Kato K; Obayashi S; Matsushima E; Kubota T
Arch Gynecol Obstet; 2011 Oct; 284(4):913-21. PubMed ID: 21120510
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice guidelines.
Vachhrajani S; Kulkarni AV; Kestle JR
J Neurosurg Pediatr; 2009 Apr; 3(4):249-56. PubMed ID: 19338401
[TBL] [Abstract][Full Text] [Related]
18. [Marketing Approval of Ethical Kampo Medicines].
Hakamatsuka T
Yakugaku Zasshi; 2017; 137(2):163-165. PubMed ID: 28154326
[TBL] [Abstract][Full Text] [Related]
19. Use of Kampo diagnosis in randomized controlled trials of Kampo products in Japan: a systematic review.
Motoo Y; Arai I; Tsutani K
PLoS One; 2014; 9(8):e104422. PubMed ID: 25119187
[TBL] [Abstract][Full Text] [Related]
20. Toxicological aspects of Kampo medicines in clinical use.
Ikegami F; Fujii Y; Ishihara K; Satoh T
Chem Biol Interact; 2003 Jun; 145(3):235-50. PubMed ID: 12732452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
